Submit
logo

Baroda BNP Paribas Health And Wellness Fund Regular IDCWPayout

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 09-06-2025
AUM:

₹ 487.35 Cr

Expense Ratio

2.74%

Benchmark

BSE Healthcare TRI

ISIN

INF251K01VD9

Minimum Investment

1000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Mr. Rohan Korde, Mr. Ankeet Pandya

Fund Performance 1Y (%) 3Y (%) 5Y (%)
Baroda BNP Paribas Health And Wellness Fund Regular IDCWPayout 5.86 - -
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
10.3161
Last change
0.22 (2.1403%)
Fund Size (AUM)
₹ 487.35 Cr
Performance
2.3% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Fund Manager
Mr. Rohan Korde, Mr. Ankeet Pandya
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 8.58
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 7.88
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 7.82
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- 6.13
LAURUS LABS LIMITED EQ NEW FV RS. 2/- 6.09
LUPIN LIMITED EQ NEW F.V. RS.2/- 5.79
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 5.28
FORTIS HEALTHCARE LIMITED. EQ 3.98
DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/- 3.47
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- 3.34

Sector Allocation

Sector Holdings (%)
Healthcare 93.48
Financial Services 2.68
Information Technology 0.9

Peer Comparison

Scheme Name 5Y (%)
Baroda BNP Paribas Health And Wellness Fund Reg IDCW Payout 0.0